drugset / Trial / NCT00296517
Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to evaluate the efficacy and safety in depressive patients who did not respond sufficiently to selective serotonin re-uptake inhibitors (SSRI).
Timeline
- Start
- 2006-01-19
- Primary completion
- 2008-03-28
- Completion
- 2008-03-28
Outcome
Missed primary endpoint
registry analysis (unspecified test); Placebo vs Bupropion SR; p = 0.805; Mean Difference (Net) 0.2 (95% CI -1.6 to 2.0); ANOVA NCT00296517 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 300 mg | — |